Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage

This publication has 31 references indexed in Scilit:

• The Effect of Temperature and pH on the Activity of Factor VIIa: Implications for the Efficacy of High-Dose Factor VIIa in Hypothermic and Acidotic Patients
  Published by Wolters Kluwer Health ,2003
• An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VII
  Anesthesia & Analgesia, 2001
• Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery
  Blood Coagulation & Fibrinolysis, 2000
• SUCCESSFUL USE OF RECOMBINANT FVIIa (NOVOSEVEN^®) IN THE MANAGEMENT OF INTRACTABLE POST‐SURGICAL INTRA‐ABDOMINAL HAEMORRHAGE
  British Journal of Haematology, 1999
• Recombinant Factor VIla (NovoSeven®) in the Treatment of Internal Bleeding in Patients with Factor VIM and IX Inhibitors
  Pathophysiology of Haemostasis and Thrombosis, 1996
• Resternotomy for bleeding after cardiac operation: A marker for increased morbidity and mortality
  The Annals of Thoracic Surgery, 1995
• THE IMPACT OF HYPOTHERMIA ON DILUTIONAL COAGULOPATHY
  Published by Wolters Kluwer Health ,1994
• Effect of hypothermia on the coagulation cascade
  Critical Care Medicine, 1992
• Factor VIIa in the treatment of haemophilia
  Blood Coagulation & Fibrinolysis, 1990
• Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.
  Journal of Clinical Investigation, 1983